Both in Pharmaceuticals
Arcus Biosciences vs Xencor
Over the past year RCUS returned −7.8% and XNCR returned +102.7%; their daily moves had a correlation of 0.42.
RCUS −7.8% XNCR +102.7%Growth of $1, one year, split-adjusted
| Metric | RCUS | XNCR |
|---|---|---|
| Price | $18.19 | $29.82 |
| Market cap | $2.32B | $2.22B |
| Today | −2.26% | +2.09% |
| 1 month | −27.9% | +20.4% |
| 6 months | −29.2% | +135.0% |
| Year to date | −23.7% | +94.8% |
| 1 year | −10.3% | +103.3% |
| Revenue growth (YoY) | −74.4% | +17.5% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −222.0% | −42.4% |
| P/E (TTM) | — | — |
| Price / sales | 19.8× | 21.1× |
| Net cash | $601.0M | $351.6M |
| Dividend yield | — | — |
| Volatility (60d) | 62.7% | 62.4% |
| Short % of float | 13.6% | 17.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).